NCT06770270View on ClinicalTrials.gov

Pucotenlimab Plus Radiotherapy and Chemotherapy for Neoadjuvant Treatment of Locally Advanced Rectal Cance(PUCRT)

PHASE2RecruitingINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

August 1, 2024

Primary Completion Date

December 31, 2027

Study Completion Date

June 30, 2030

Conditions
Rectal Cancer
Interventions
DRUG

Pucotenlimab

"Pucotenlimab combined with long-course concurrent chemoradiotherapy, followed by two cycles of pucotenlimab combined with chemotherapy, and then based on tumor response, TME surgery or a watch and wait strategy will be adopted."

Trial Locations (1)

310009

RECRUITING

Second Affiliated Hospital Of Zhejiang University School of Medicine, Hangzhou

All Listed Sponsors
lead

Second Affiliated Hospital, School of Medicine, Zhejiang University

OTHER